233 related articles for article (PubMed ID: 9753484)
1. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
3. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.
Oldenburg B; Van Tuyl BA; van der Griend R; Fijnheer R; van Berge Henegouwen GP
Dig Dis Sci; 2005 Feb; 50(2):235-40. PubMed ID: 15745078
[TBL] [Abstract][Full Text] [Related]
5. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease.
Papa A; De Stefano V; Gasbarrini A; Chiusolo P; Cianci R; Casorelli I; Paciaroni K; Cammarota G; Leone G; Gasbarrini G
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):499-503. PubMed ID: 10937811
[TBL] [Abstract][Full Text] [Related]
7. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
Weitz IC; Israel VK; Liebman HA
Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease.
Guédon C; Le Cam-Duchez V; Lalaude O; Ménard JF; Lerebours E; Borg JY
Am J Gastroenterol; 2001 May; 96(5):1448-54. PubMed ID: 11374681
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.
Vandenbroucke JP; Koster T; Briët E; Reitsma PH; Bertina RM; Rosendaal FR
Lancet; 1994 Nov; 344(8935):1453-7. PubMed ID: 7968118
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
Mahmood A; Needham J; Prosser J; Mainwaring J; Trebble T; Mahy G; Ramage J
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):739-44. PubMed ID: 15947551
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia.
Lee DH; Warkentin TE; Denomme GA; Lagrotteria DD; Kelton JG
Thromb Haemost; 1998 Jan; 79(1):50-3. PubMed ID: 9459322
[TBL] [Abstract][Full Text] [Related]
14. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis.
Liang J; Wu S; Feng B; Lei S; Luo G; Wang J; Li K; Li X; Xie H; Zhang D; Wang X; Wu K; Miao D; Fan D
J Gastroenterol; 2011 Oct; 46(10):1158-66. PubMed ID: 21805067
[TBL] [Abstract][Full Text] [Related]
17. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
[TBL] [Abstract][Full Text] [Related]
18. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
[TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.
Olave T; Cornudella R; Homs C; Azaceta G; Tirado I; Gutierrez M
Haematologica; 1998 Apr; 83(4):378-80. PubMed ID: 9592991
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis.
Vecchi M; Sacchi E; Saibeni S; Meucci G; Tagliabue L; Duca F; De Franchis R
Dig Dis Sci; 2000 Jul; 45(7):1465-9. PubMed ID: 10961731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
